Non-alcoholic fatty liver disease natural history, complications and prognosis: Difference between revisions
Aditya Ganti (talk | contribs) No edit summary |
|||
Line 14: | Line 14: | ||
**2) Patients with [[NASH]] has more liver-related mortality rate | **2) Patients with [[NASH]] has more liver-related mortality rate | ||
* If left untreated, patients with NAFLD may progress to develop hepato-cellular carcinoma ([[HCC]]). But it is directly propotional to the degree of [[fibrosis]] and advanced [[cirrhosis]] | * If left untreated, patients with NAFLD may progress to develop hepato-cellular carcinoma ([[HCC]]). But it is directly propotional to the degree of [[fibrosis]] and advanced [[cirrhosis]] | ||
* Children who are positive with NAFLD are also prone to short lifespan when compared to general population. | * Children who are positive with NAFLD are also prone to short lifespan when compared to general population.<ref name="pmid27213358">{{cite journal| author=Calzadilla Bertot L, Adams LA| title=The Natural Course of Non-Alcoholic Fatty Liver Disease. | journal=Int J Mol Sci | year= 2016 | volume= 17 | issue= 5 | pages= | pmid=27213358 | doi=10.3390/ijms17050774 | pmc=4881593 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27213358 }} </ref><ref name="pmid16012941">{{cite journal| author=Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A et al.| title=The natural history of nonalcoholic fatty liver disease: a population-based cohort study. | journal=Gastroenterology | year= 2005 | volume= 129 | issue= 1 | pages= 113-21 | pmid=16012941 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16012941 }} [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17213068 Review in: Evid Based Med. 2006 Feb;11(1):26] [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16388571 Review in: ACP J Club. 2006 Jan-Feb;144(1):22] </ref> | ||
===Complications=== | ===Complications=== |
Revision as of 00:37, 29 December 2017
Non-Alcoholic Fatty Liver Disease Microchapters |
Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases |
---|
Diagnosis |
Treatment |
Case studies |
Non-alcoholic fatty liver disease natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Non-alcoholic fatty liver disease natural history, complications and prognosis |
FDA on Non-alcoholic fatty liver disease natural history, complications and prognosis |
CDC on Non-alcoholic fatty liver disease natural history, complications and prognosis |
Non-alcoholic fatty liver disease natural history, complications and prognosis in the news |
Blogs on Non-alcoholic fatty liver disease natural history, complications and prognosis |
Directions to Hospitals Treating Non-alcoholic fatty liver disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
If left untreated non alcoholic fatty liver disease may progress to fibrosis and, later cirrhosis. Studies of serial liver biopsies estimate a 26-37% rate of hepatic fibrosis and 2-15% rate of cirrhosis in less than 6 years. Common complications of NAFLD include fibrosis, cirrhosis, internal bleeding, encepholopathy. The presence of fibrosis and cirrhosis associated with a particularly poor prognosis among patients with NAFLD.
Natural History, Complications and Prognosis
Natural History
- The symptoms of NAFLD usually develop in the 40th decade of life, and usually asymptomatic at first.
- After following NAFLD patients for long-term the outcome of the disease is as follows [1]
- If left untreated, patients with NAFLD may progress to develop hepato-cellular carcinoma (HCC). But it is directly propotional to the degree of fibrosis and advanced cirrhosis
- Children who are positive with NAFLD are also prone to short lifespan when compared to general population.[2][3]
Complications
- Common complications of NAFLD include:[4][5][6][7]
- Fibrosis
- Cirrhosis
- Internal bleeding
- Encepholopathy
Prognosis
- Depending on the extent of the fibrosis and cirrhosis at the time of diagnosis, the prognosis may vary.[8]
- Histology is the most reliable means to grade the severity of the disease and thus estimate prognosis.
- The presence of fibrosis and cirrhosis associated with a particularly poor prognosis among patients with NAFLD. [9][10]
References
- ↑ "The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology - Gastroenterology".
- ↑ Calzadilla Bertot L, Adams LA (2016). "The Natural Course of Non-Alcoholic Fatty Liver Disease". Int J Mol Sci. 17 (5). doi:10.3390/ijms17050774. PMC 4881593. PMID 27213358.
- ↑ Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A; et al. (2005). "The natural history of nonalcoholic fatty liver disease: a population-based cohort study". Gastroenterology. 129 (1): 113–21. PMID 16012941. Review in: Evid Based Med. 2006 Feb;11(1):26 Review in: ACP J Club. 2006 Jan-Feb;144(1):22
- ↑ "Nonalcoholic Fatty Liver Disease Symptoms, Causes, and More".
- ↑ Armstrong MJ, Adams LA, Canbay A, Syn WK (2014). "Extrahepatic complications of nonalcoholic fatty liver disease". Hepatology. 59 (3): 1174–97. doi:10.1002/hep.26717. PMID 24002776.
- ↑ Chacko KR, Reinus J (2016). "Extrahepatic Complications of Nonalcoholic Fatty Liver Disease". Clin Liver Dis. 20 (2): 387–401. doi:10.1016/j.cld.2015.10.004. PMID 27063276.
- ↑ Vanni E, Marengo A, Mezzabotta L, Bugianesi E (2015). "Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander". Semin Liver Dis. 35 (3): 236–49. doi:10.1055/s-0035-1562944. PMID 26378641.
- ↑ Suman, A.; Khullar, V.; Limaye, A. (2016). "Complications of Non-Alcoholic Fatty Liver Disease". Journal of Hepatology. 64 (2): S473. doi:10.1016/S0168-8278(16)00798-4. ISSN 0168-8278.
- ↑ Jepsen P, Grønbæk H (2011). "Prognosis and staging of non-alcoholic fatty liver disease". BMJ. 343: d7302. doi:10.1136/bmj.d7302. PMID 22102440.
- ↑ "Nonalcoholic Fatty Liver Disease".